Objects
Liu, Zheng, Martin, Jennifer H., Hatzimihalis, Athena, Campbell, Ian, Crowley, Simone, Beale, Phillip J., Karapetis, Christos S., Price, Timothy, Burge, Mathew E., Michael, Michael, Liauw, Winston, Mclachlan, Sue-Anne, Link, Emma, Matera, Anetta, Thompson, Michael, Jefford, Michael, Hicks, Rod J., Cullinane, Carleen. Springer; 2021. Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val. Springer; 2011. Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.
Shapiro, Jeremy D., Thavaneswaran, Subotheni, Tebbutt, Niall C., Price, Timothy J., Khasraw, Mustafa, Van Hazel, Guy A., Waring, Paul M., Tejpar, Sabine, Simes, John, Gebski, Val J., Desai, Jayesh, Segelov, Eva, Underhill, Craig R., Robledo, Kristy P., Karapetis, Chistos S., Day, Fiona L., Nott, Louise M., Jefford, Michael, Chantrill, Lorraine A., Pavlakis, Nick. Elsevier; 2018. Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
Eakin, Elizabeth G., Reeves, Marina M., Koczwara, Bogda, Saunders, Christobel M., Chapman, Kathy, Hing, Liz, Boltong, Anna G., Lane, Katherine, Baldwin, Polly, Millar, Lesley, McKiernan, Sandy, Demark-Wahnefried, Wendy, Goode, Ana D., Courneya, Kerry S., Job, J, Reid, N, Robson, E, Moretto, N, Gordon, L, Hayes, SC, Winkler, Elisabeth A. H., Vardy, Janette L., Boyle, Frances, Haas, Marion R., Hiller, Janet E., Mishra, Gita D., Jefford, Michael. BioMed Central (BMC); 2020. Translating research into practice: Outcomes from the Healthy Living after Cancer partnership project.